Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > PharmaGuy42
View:
Post by blartar on Jan 26, 2016 10:41am

PharmaGuy42

you mentioned    " MAPI group "  was helping Telesta with their presentations. Do you know what division it is ?      Canada,  USA,  Europe,  etc etc .  Do you have a source for that info, I can't find it on the Telesta web site ?  TIA
Comment by PharmaGuy42 on Jan 26, 2016 11:44am
Hmm.. Strange, I was positive it was on the website... I fear now that it may not have been public information perhaps. If that is the case, I'll retract my comment until I find a source for it. However, my statement that their regulatory affairs is. whether in whole or in part, not being done in-house can conclusively be backed up in the following document: https://www.telestatherapeutics ...more  
Comment by blartar on Jan 26, 2016 12:19pm
I could find this  ;    A recent commercial assessment, conducted by Medical Marketing Economics (“MME”), a global leader in the development of value-based strategies and market research, employed rigorous qualitative and quantitative primary market research but I was hoping that   MAPI   were using their USA division for the FDA every little bit helps.   ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities